Clinical trial
HAT in Eye Complications of Behcet's Disease
NCT00001865 · National Eye Institute (NEI), NIH · Completed
Key facts
| NCT number | NCT00001865 |
|---|---|
| Title | HAT in Eye Complications of Behcet's Disease |
| Official title | A Study to Investigate the Safety and Efficacy of HAT to Treat the Ocular Complications Related to Behcet's Disease |
| Lead sponsor | National Eye Institute (NEI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Behcet's Syndrome, Retinal Disease, Uveitis |
| Intervention type | Drug |
| Interventions | Daclizumab |
| Enrollment | 26 |
| Start date | Jul 1, 1999 |
| Completion | Jun 1, 2004 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: